Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer cells and nonprostatic solid tumor neovasculature and is a target for anticancer imaging and therapeutic agents. PSMA acts as a glutamate carboxypeptidase (GCPII) on small molecule substrates, including folate, the anticancer drug methotrexate, and the neuropeptide N -acetyl- l -aspartyl- l -glutamate. Here we present the 3.5-Å crystal structure of the PSMA ectodomain, which reveals a homodimer with structural similarity to transferrin receptor, a receptor for iron-loaded transferrin that lacks protease activity. Unlike transferrin receptor, the protease domain of PSMA contains a binuclear zinc site, catalytic residues, and a proposed substrate-binding arginine patch. Elucidation of the PSMA structure combined with docking studies and a proposed catalytic mechanism provides insight into the recognition of inhibitors and the natural substrate N -acetyl- l -aspartyl- l -glutamate. The PSMA structure will facilitate development of chemotherapeutics, cancer-imaging agents, and agents for treatment of neurological disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
Ghosh, A., & Heston, W. D. W. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10661 · Cited by 878
Molecular Cloning of Transferrin Receptor 2
Kawabata, H., Yang, R., Hirama, T., Vuong, P. T., Kawano, S., Gombart, A. F., & Koeffler, H. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.20826 · Cited by 650
Structure of the human transferrin receptor-transferrin complex
Cheng, Y., Zak, O., Aisen, P., Harrison, S. C., & Walz, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00130-8 · Cited by 571
[10] Electron-density map interpretation
Jones, T. A., & Kjeldgaard, M. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77012-5 · Cited by 505
Constitutive and antibody-induced internalization of prostate-specific membrane antigen.
Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R., & Bander, N. H. (1998) · PubMed · Cited by 458
Refined crystal structure of carboxypeptidase a at 1·54 Å resolution
Rees, D. C., Lewis, M., & Lipscomb, W. N. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80024-2 · Cited by 399
Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C. H., Lin, S., Tong, W. P., May, F., Mukherjee, B., & Heston, W. D. W. (1996) · PubMed · Cited by 389
Research works printed but not linked: 8
- 10.1002/(SICI)1097-0045(20000201)42:2<145::AID-PROS9>3.0.CO;2-Q · doi:10.1002/(sici)1097-0045(20000201)42:2<145::aid-pros9>3.0.co;2-q
- Pinto, J. T., Suffoletto, B. P., Berzin, T. M., Qiao, C. H., Lin, S., Tong, W. P., May, F., Mukhrjee, B. & Heston, W. D. W. (1996) Clin. Cancer Res. 2, 1445-1451.9816319
- Neale, J. H., Bzdega, T. & Wroblewska, B. (2000) J. Neurochem. 2000, 443-452.
- Liu, H., Rajasekaran, A. K., Moy, P., Xia, Y., Kim, S., Navarro, V., Rahmati, R. & Bander, N. H. (1998) Cancer Res. 58, 4055-4060.9751609
- Grauer, L. S., Lawler, K. D., Marignac, J. L., Kumar, A., Goel, A. S. & Wolfert, R. L. (1998) Cancer Res. 58, 4787-4789.9809977
- Turk D. (1992) Ph.D. thesis (Technische Universität Munich Germany).
- Lipscomb, W. N., Hartsuck, J. A., Reeke, G. N., Quiocho, F. A., Bethge, P. H., Ludwig, M. L., Steitz, T. A., Muirhead, H. & Coppola, J. C. (1969) Brookhaven Symp. Biol. 21, 24-90.
- 10.1111/j.1574-6976.1996.tb00247.x · doi:10.1111/j.1574-6976.1996.tb00247.x · Paper page
Cited by
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M. A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., et al. (2020) · Nature · doi:10.1038/s41586-020-2852-1 · Cited by 1,599
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Chen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer
Mesters, J. R., Barinka, C., Li, W., Tsukamoto, T., Majer, P., Slusher, B. S., Konvalinka, J., & Hilgenfeld, R. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600969 · Cited by 284
“Unfortunately, this is also true for a model derived from a very-low-resolution (3.5 Å) crystal structure of PSMA that was described recently (Davis et al, 2005).”
BackgroundInfluentialAntisense-mediated exon skipping: A versatile tool with therapeutic and research applications
Aartsma-Rus, A., & van Ommen, G.-J. B. (2007) · RNA · doi:10.1261/rna.653607 · Cited by 267
“The overexpressed isoform has a functional enzymatic domain that is located extracellularly and regulates folate uptake (Davis et al. 2005).”
Background
Metadata
- Authors
- Davis, M. I., Bennett, M. J., Thomas, L. M., & Bjorkman, P. J.
- Affiliations
- California Institute of Technology (US)
- Division of Biology 114-96 and Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-04-18
- Volume
- 102
- Issue
- 17
- Pages
- 5981-5986
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC556220
- OpenAlex
- W2006664751
- Cited by
- 296
- References
- 56
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 20 · 2023: 18 · 2022: 19 · 2021: 24 · 2020: 19 · 2019: 14 · 2018: 7 · 2017: 9 · 2016: 15 · 2015: 4 · 2014: 9 · 2013: 8 · 2012: 19
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- U.S. Department of Defense
- Howard Hughes Medical Institute
- American Liver Foundation
- California Institute of Technology
- Georgetown University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Keywords
- prostate-specific membrane antigen, crystal structure, homodimer, catalytic mechanism, substrate binding, methotrexate, folic acid, tumor markers, prostate cancer, neovasculature
- MeSH terms
- Amino Acid Sequence, Antigens, Surface, Binding Sites, Cloning, Molecular, Humans, Male, Models, Molecular, Molecular Sequence Data, Protein Conformation, Substrate Specificity, Biomarkers, Tumor, Protein Structure, Secondary, DNA, Complementary, Glutamate Carboxypeptidase II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. https://app.cochat.ai/papers/10.1073/pnas.0502101102
- The paper
- Davis, M. I., Bennett, M. J., Thomas, L. M., & Bjorkman, P. J. (2005). Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0502101102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.